Sponsor

Which mRNA Vaccine Works Better Over Time?

0
168

The continued emergence of SARS-CoV-2 variants and breakthrough infections following vaccination underscore the need to study the effectiveness of current COVID-19 vaccines in the real world.

To date, only two mRNA COVID-19 vaccines have been approved for marketing, mRNA-1273 developed by Moderna and BNT162b2 developed by Pfizer/BioNTech, which have proven to be very effective in preventing severe illness, hospitalization and death due to SARS-CoV-2 infections.

However, the two mRNA vaccines induced different humoral immune responses, with data showing that humoral antibody responses were significantly higher with two doses of mRNA-1273 vaccine than with two doses of BNT162b2 vaccine. The higher humoral antibody response implies greater protection against SARS-CoV-2. In addition, there are data showing that breakthrough infections were higher after two doses of BNT162b2 vaccine than after two doses of mRNA-1273 vaccine during the Delta epidemic. These suggest to us that the two mRNA vaccines may have different effects in the real world.

On May 2, 2022, researchers at Optum Labs, a scientific healthcare organization, published a research paper in Nature Communications titled: Comparative effectiveness over time of the mRNA-1273 (Moderna) vaccine and the BNT162b2 (Pfizer-BioNTech) vaccine.

This retrospective cohort study of nearly 4 million individuals in the United States who received two doses of mRNA-1273 or BNT162b2 vaccine investigated the relationship between their severity of infection and the timing of vaccination to understand the actual performance and comparative effectiveness of these two mRNA vaccines. The primary outcome of this study was the rate of SARS-CoV-2 infections on days 30, 60, and 90 after the second dose of mRNA-1273 vaccine or BNT162b2 vaccination.

Of the nearly 4 million individuals who received two doses of mRNA-1273 vaccine (40%) or BNT162b2 vaccine (60%), a total of 8,848 were documented to be infected with SARS-CoV-2, of which 3,090 (35%) had previously received mRNA-1273 vaccine and 5,758 (65%) had previously received BNT162b2 vaccine.

Statistical results showed significant differences in infections over time between mRNA-1273 vaccination and BNT162b vaccination, with a lower probability of acquiring COVID-19 over time after mRNA-1273 vaccination. However, there was no statistically significant difference between the two mRNA vaccines over time for hospitalization, admission to the ICU, death, or transfer to hospice care.

This large retrospective analysis shows that there is a significant difference in the prevention of SARS-CoV-2 infections after mRNA-1273 vaccination and BNT162b vaccination, and that this difference is widening over time. The data show that for every 1 million people who received two doses of mRNA vaccine, there were 3,448 more breakthrough infections in people who received BNT162b vaccine than those who received mRNA-1273 vaccine at day 90.

Overall, mRNA-1273 vaccination was slightly more effective than BNT162b vaccination in preventing infection after complete vaccination. However, both vaccines were comparable in terms of protection against serious illness (hospitalization, ICU, or death) within 90 days of complete vaccination.

Zoeken
Sponsor
Sponsor
Search Hotels
Categorieën
Read More
Other
Cold Agglutinin Disease Market  Upcoming Trends: Innovation, Share Analysis, Size, Value, Status, and Demand
Latest "Cold Agglutinin Disease Market" Size, Share & Trends Analysis Research Report 2024 -...
By DevP2210 2024-05-06 18:39:25 0 884
Other
Massey Ferguson Tractor Price in India 2024 - TractorGyan
Massey Ferguson Tractor is a tractor that is in high demand in the market, and customers have an...
By tractorgyann01 2024-01-29 10:04:49 0 931
Networking
Dry Whole Milk Market Growth, Share, Demand and Applications Forecast to 2030
Global Dry Whole Milk Market size was valued at $11.71 Billion in 2023 and is expected to reach...
By maximizemangesh 2024-05-15 04:35:59 0 648
Other
Medicinal Mushroom Market Is Expected to Grow at a CAGR of 9.85% by 2029
A comprehensive Medicinal Mushroom Market research report delivers up-to-date data and...
By mpradipm 2024-11-14 12:41:33 0 88
IT
Cash Flow Management Market Pioneers New Solutions for Industry Challenges
The Cash Flow Management Market size was USD 727.3 million in 2023 and is expected...
By kavyab 2024-11-07 06:24:13 0 102